|
|
Volumn 12, Issue 3, 2013, Pages 178-
|
|
Trial watch: Pioneering RNAi therapy shows antitumour activity in humans
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
KINESIN;
NANOPARTICLE;
SMALL INTERFERING RNA;
VASCULOTROPIN;
ADVANCED CANCER;
ANTINEOPLASTIC ACTIVITY;
CANCER GENE THERAPY;
CANCER GROWTH;
CANCER REGRESSION;
CELL MATURATION;
DRUG DOSE ESCALATION;
DRUG SAFETY;
DRUG TOLERABILITY;
ENDOMETRIUM CANCER;
FATIGUE;
FEVER;
GENE SILENCING;
GENE TARGETING;
HUMAN;
KIDNEY CARCINOMA;
LIPOSOMAL DELIVERY;
LIVER BIOPSY;
LIVER METASTASIS;
LIVER TUMOR;
NAUSEA;
NOTE;
PANCREATIC NEUROENDOCRINE TUMOR;
PHASE 1 CLINICAL TRIAL (TOPIC);
PRIORITY JOURNAL;
RNA INTERFERENCE;
SOLID TUMOR;
CLINICAL TRIALS, PHASE I AS TOPIC;
HUMANS;
NEOPLASMS;
RNA INTERFERENCE;
|
|
EID: 84875179206
PISSN: 14741776
EISSN: 14741784
Source Type: Journal
DOI: 10.1038/nrd3962 Document Type: Note |
|
Times cited : (11)
|
|
References (0)
|
